Trust CO Of Vermont Actinium Pharmaceuticals, Inc. Transaction History

Trust CO Of Vermont

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	BUY	$4.71 - $7.11 $235 - $355	50 New	50 $0
Q1 2022 Apr 05, 2022	SELL	$4.57 - $6.4 $228 - $320	-50 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$6.01 - $8.8 $300 - $440	50 New	50 $0
Q3 2021 Oct 22, 2021	SELL	$5.76 - $9.67 $288 - $483	-50 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$7.26 - $18.0 $363 - $900	50 New	50 $0

6.65M

369K

148K

Ticker ATNM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,184,700
Market Cap $175M
Description
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

Stay updated on Trust CO Of Vermont with notifications on news.